COPD and Immunotherapy in NSCLC
Author Summary

COPD and Immunotherapy in NSCLC

September 8, 2025 0

Background and rationale Lung cancer remains the leading cause of cancer-related mortality worldwide; non-small cell lung cancer (NSCLC) accounts for about 85% of cases. Despite advances, prognosis is poor, especially at advanced stages. Immune checkpoint […]

Menopause and T-Helper Cells in Women With AMI
Author Summary

Menopause and T-Helper Cells in Women With AMI

September 5, 2025 0

Short take: In a proof-of-concept study of women hospitalized with acute myocardial infarction (AMI), researchers found sex-specific immune differences—women showed more CD4+ T cells and a shift toward Th1—but menopausal status itself did not meaningfully […]

Pollution and Epigenetics: A Hidden Driver of Diabetes
Author Summary

Pollution and Epigenetics: A Hidden Driver of Diabetes

September 3, 2025 0

Uncovering How Environmental Chemicals May Influence Gene Expression and Increase Diabetes Risk Diabetes: A Global Burden with Complex Causes Diabetes mellitus (DM) is one of the most widespread metabolic diseases globally. Characterized by elevated blood […]

Novel lncRNA Co-methylation Signatures in Breast Cancer
Author Summary

Novel lncRNA Co-methylation Signatures in Breast Cancer

August 13, 2025 0

Introduction: Unraveling the Epigenetic Landscape of Breast Cancer “Breast cancer is the most commonly diagnosed malignancy in women. Despite advances in diagnostics and treatment, the key molecular mechanisms underlying its development remain incompletely understood.” This […]

WFDC3: Novel Prognostic Biomarker in Pancreatic Cancer
Author Summary

WFDC3: Novel Prognostic Biomarker in Pancreatic Cancer

August 8, 2025 0

Introduction: The Challenge of Pancreatic Cancer Pancreatic ductal adenocarcinoma (PAAD) remains one of the deadliest cancers, with a five-year survival rate near 10%. Its silent onset, rapid spread, and resistance to current treatments make early […]